|
2024
|
Invention
|
Novel use of an ileal bile acid transporter inhibitor for the treatment of pruritus. The present ... |
|
|
Invention
|
Chemical compounds and uses thereof. Disclosed herein are certain chemical compounds that inhibit... |
|
|
Invention
|
Covalent multi-specific antibody. Disclosed herein are novel bispecific and tri-specific antibodi... |
|
|
Invention
|
Treatment of pruritus with p2x3 modulators.
Methods of treating pruritus in a mammal with a P2X3... |
|
|
Invention
|
Thiadiazolyl derivatives as dna polymerase theta inhibitors and uses thereof.
Disclosed herein a... |
|
|
Invention
|
Human trpm3 inhibitors for use in the treatment of epilepsy. The present disclosure relates to an... |
|
|
Invention
|
Biopharmaceutical compositions. The present disclosure relates to compositions for treating inter... |
|
|
Invention
|
Combination therapy comprising a mat2a inhibitor and a topoisomerase inhibitor, a splicing inhibi... |
|
|
Invention
|
Methods for treating and monitoring cancer. The disclosure provides a method of treating cancer i... |
|
|
Invention
|
H)-ol. The invention provides a method for preparing 3-(aminomethyl)-4-chloro-7-(2- hydroxyethoxy... |
|
|
Invention
|
Deuterated p2x3 modulators. Provided herein are deuterated P2X3 modulators and methods of utilizi... |
|
2023
|
Invention
|
Daprodustat for reducing fatigue. The present invention relates to daprodustat or a pharmaceutica... |
|
|
Invention
|
Thiadiazolyl derivatives as dna polymerase theta inhibitors and uses thereof. Disclosed herein ar... |
|
|
Invention
|
Antigen binding proteins. The present disclosure relates to FLT3LG binding proteins that inhibit ... |
|
|
Invention
|
Novel formulation. The present disclosure relates to a dispersible tablet capable of disintegrati... |
|
|
Invention
|
Novel use. The present disclosure relates to an inhibitor of human TRPM3 for use in the treatment... |
|
|
Invention
|
Antigen binding proteins. The present disclosure relates to a ULBP6 binding protein that inhibits... |
|
|
Invention
|
Crystalline forms of gsk1278863, preparation method and pharmaceutical use thereof.
The present ... |
|
|
Invention
|
Inhibitors of human slc7a3 for the treatment of endometriosis or uterine fibroids. The present di... |
|
|
Invention
|
Combination therapy comprising a mat2a inhibitor and an antimetabolite agent. Provided herein is ... |
|
|
Invention
|
Prevention and treatment of headaches. The present disclosure relates to use of artemin inhibitor... |
|
|
Invention
|
Imidazopyridine compounds and uses thereof.
This invention generally relates to substituted imid... |
|
2022
|
Invention
|
Thiadiazolyl compounds as dna polymerase theta inhibitors. Disclosed herein are certain thiadiazo... |
|
|
Invention
|
Cyclic vinyl sulfone compounds as wrn inhibitors. Disclosed herein are certain succinamido deriva... |
|
|
Invention
|
Selective p2x3 modulators.
Provided herein are methods for the treatment of avoiding loss of tas... |
|
|
Invention
|
2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodo... |
|
|
Invention
|
Preparation of p2x3 antagonist.
Described herein is the preparation of a P2X3 antagonist and che... |
|
|
Invention
|
Biopharmaceutical compositions.
The present disclosure relates to compositions for treating inte... |
|
|
Invention
|
O-linked thiadiazolyl compounds as dna polymerase theta inhibitors.
Disclosed herein are certain... |
|
|
Invention
|
O-linked thiadiazolyl compounds as dna polymerase theta inhibitors. Disclosed herein are certain ... |
|
|
Invention
|
Biopharmaceutical compositions and methods for pediatric patients.
The present disclosure relate... |
|
|
Invention
|
Combination therapy comprising a mat2a inhibitor and type i prmt inhibitor.
Provided herein is a... |
|
|
Invention
|
Combination therapy comprising a mat2a inhibitor and type i prmt inhibitor. Provided herein is a ... |
|
|
Invention
|
Novel use.
The present disclosure relates to an inhibitor of human TRPM3 for use in the treatmen... |
|
2021
|
Invention
|
Forms of linerixibat.
Disclosed are crystalline and amorphous forms of linerixibat and pharmaceu... |
|
|
Invention
|
Methods for treating cholestatic pruritus.
Methods of treating pruritus, including cholestatic p... |
|
|
Invention
|
Daprodustat for reducing fatigue in a subject with anemia associated with chronic kidney disease.... |
|
|
Invention
|
Novel manufacturing method of daprodustat and precursors thereof.
The present disclosure relates... |
|
|
Invention
|
Novel manufacturing method of daprodustat and precursors thereof. The present disclosure relates ... |
|
|
Invention
|
Formulation comprising daprodustat.
The present disclosure relates to an immediate release table... |
|
|
Invention
|
P2x3 modulators.
Provided herein are P2X3 modulators and methods of utilizing P2X3 modulators in... |
|
|
Invention
|
Preparation of a p2x3 antagonist.
Described herein are two processes for the preparation of meth... |
|
2020
|
Invention
|
Covalent multi-specific antibody.
Disclosed herein are novel bispecific and tri-specific antibod... |
